Application 020049
- Type
- NDA
- Sponsor
- SHIRE
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | PENTASA | MESALAMINE | CAPSULE, EXTENDED RELEASE;ORAL | 250MG | Yes | No |
| 002 | PENTASA | MESALAMINE | CAPSULE, EXTENDED RELEASE;ORAL | 500MG | Yes | Yes |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N020049-001 | PENTASA | MESALAMINE | 250MG | CAPSULE, EXTENDED RELEASE / ORAL | AB | RLD | 1993-05-10 |
| N020049-002 | PENTASA | MESALAMINE | 500MG | CAPSULE, EXTENDED RELEASE / ORAL | AB | RLD, RS | 2004-07-08 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| N020049-001 | AB |
| N020049-002 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-11-14 07:37:17 | 2026-10 | N020049-001 | PENTASA | 250MG | CAPSULE, EXTENDED RELEASE / ORAL | AB | RLD | 1993-05-10 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N020049-002 | PENTASA | 500MG | CAPSULE, EXTENDED RELEASE / ORAL | AB | RLD, RS | 2004-07-08 | d4dbc9d85df4… |
| 2026-10-15 13:18:30 | 2026-09 | N020049-001 | PENTASA | 250MG | CAPSULE, EXTENDED RELEASE / ORAL | AB | RLD | 1993-05-10 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | N020049-002 | PENTASA | 500MG | CAPSULE, EXTENDED RELEASE / ORAL | AB | RLD, RS | 2004-07-08 | c2088c7a36db… |
| 2026-09-14 22:38:34 | 2026-08 | N020049-001 | PENTASA | 250MG | CAPSULE, EXTENDED RELEASE / ORAL | AB | RLD | 1993-05-10 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N020049-002 | PENTASA | 500MG | CAPSULE, EXTENDED RELEASE / ORAL | AB | RLD, RS | 2004-07-08 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | N020049-001 | PENTASA | 250MG | CAPSULE, EXTENDED RELEASE / ORAL | AB | RLD | 1993-05-10 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N020049-002 | PENTASA | 500MG | CAPSULE, EXTENDED RELEASE / ORAL | AB | RLD, RS | 2004-07-08 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | N020049-001 | PENTASA | 250MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 1993-05-10 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N020049-002 | PENTASA | 500MG | CAPSULE, EXTENDED RELEASE / ORAL | AB | RLD, RS | 2004-07-08 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020049-001 | PENTASA | 250MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 1993-05-10 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020049-002 | PENTASA | 500MG | CAPSULE, EXTENDED RELEASE / ORAL | AB | RLD, RS | 2004-07-08 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | N020049-001 | PENTASA | 250MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 1993-05-10 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N020049-002 | PENTASA | 500MG | CAPSULE, EXTENDED RELEASE / ORAL | AB | RLD, RS | 2004-07-08 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020049-001 | PENTASA | 250MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 1993-05-10 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020049-002 | PENTASA | 500MG | CAPSULE, EXTENDED RELEASE / ORAL | AB | RLD, RS | 2004-07-08 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N020049-001 | PENTASA | 250MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 1993-05-10 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N020049-002 | PENTASA | 500MG | CAPSULE, EXTENDED RELEASE / ORAL | AB | RLD, RS | 2004-07-08 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N020049-001 | PENTASA | 250MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 1993-05-10 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N020049-002 | PENTASA | 500MG | CAPSULE, EXTENDED RELEASE / ORAL | AB | RLD, RS | 2004-07-08 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N020049-001 | PENTASA | 250MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 1993-05-10 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N020049-002 | PENTASA | 500MG | CAPSULE, EXTENDED RELEASE / ORAL | AB | RLD, RS | 2004-07-08 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N020049-001 | PENTASA | 250MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 1993-05-10 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N020049-002 | PENTASA | 500MG | CAPSULE, EXTENDED RELEASE / ORAL | AB | RLD, RS | 2004-07-08 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N020049-001 | PENTASA | 250MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 1993-05-10 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N020049-002 | PENTASA | 500MG | CAPSULE, EXTENDED RELEASE / ORAL | AB | RLD, RS | 2004-07-08 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | N020049-001 | PENTASA | 250MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 1993-05-10 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | N020049-002 | PENTASA | 500MG | CAPSULE, EXTENDED RELEASE / ORAL | AB | RLD, RS | 2004-07-08 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N020049-001 | PENTASA | 250MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 1993-05-10 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N020049-002 | PENTASA | 500MG | CAPSULE, EXTENDED RELEASE / ORAL | AB | RLD, RS | 2004-07-08 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N020049-001 | PENTASA | 250MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 1993-05-10 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N020049-002 | PENTASA | 500MG | CAPSULE, EXTENDED RELEASE / ORAL | AB | RLD, RS | 2004-07-08 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N020049-001 | PENTASA | 250MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 1993-05-10 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N020049-002 | PENTASA | 500MG | CAPSULE, EXTENDED RELEASE / ORAL | AB | RLD, RS | 2004-07-08 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | N020049-001 | PENTASA | 250MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 1993-05-10 | 8072bd15b7f6… | |
| 2024-05-31 18:47 UTC | 2024-05 | N020049-002 | PENTASA | 500MG | CAPSULE, EXTENDED RELEASE / ORAL | AB | RLD, RS | 2004-07-08 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N020049-001 | PENTASA | 250MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 1993-05-10 | 5c6f7cd8ea54… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N020049-002 | PENTASA | 500MG | CAPSULE, EXTENDED RELEASE / ORAL | AB | RLD, RS | 2004-07-08 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | N020049-001 | PENTASA | 250MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 1993-05-10 | 5d02ea3f76ae… | |
| 2022-04-08 23:34 UTC | 2022-04 | N020049-002 | PENTASA | 500MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD, RS | 2004-07-08 | 5d02ea3f76ae… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-11-14 07:37:17 | 2026-10 | N020049-001 | AB | 1 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N020049-002 | AB | 1 | d4dbc9d85df4… |
| 2026-10-15 13:18:30 | 2026-09 | N020049-001 | AB | 1 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | N020049-002 | AB | 1 | c2088c7a36db… |
| 2026-09-14 22:38:34 | 2026-08 | N020049-001 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N020049-002 | AB | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | N020049-001 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N020049-002 | AB | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | N020049-002 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020049-002 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | N020049-002 | AB | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020049-002 | AB | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N020049-002 | AB | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N020049-002 | AB | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N020049-002 | AB | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N020049-002 | AB | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N020049-002 | AB | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | N020049-002 | AB | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N020049-002 | AB | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N020049-002 | AB | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N020049-002 | AB | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | N020049-002 | AB | 1 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N020049-002 | AB | 1 | 5c6f7cd8ea54… |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N020049-002 | AB | 1 | 6a51e52b5d6a… |
| 2024-02-18 07:12 UTC | 2024-02 | N020049-002 | AB | 1 | 1c564ffb4f44… |
| 2023-12-20 04:57 UTC | 2023-12 | N020049-002 | AB | 1 | ea1830bbd6c7… |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N020049-002 | AB | 1 | a72a2bbeb626… |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N020049-002 | AB | 1 | 9b2671bbb829… |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N020049-002 | AB | 1 | a67488948f0b… |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N020049-002 | AB | 1 | 3f0d92c62455… |
| 2023-05-13 08:27 UTC | 2023-05 | N020049-002 | AB | 1 | 053a50430f4f… |
| 2023-01-26 05:58 UTC | 2023-01 | N020049-002 | AB | 1 | 3bdfa0b2c4d7… |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N020049-002 | AB | 1 | 3a93d1ddd44b… |
| 2022-10-28 04:53 UTC | 2022-10 | N020049-002 | AB | 1 | f41ea6bd6efb… |
| 2022-09-29 23:25 UTC | 2022-09 | N020049-002 | AB | 1 | e64feba35796… |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | N020049-002 | AB | 1 | cb3db0bc1861… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N020049-001 | AB | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N020049-002 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Mesalamine | MESALAMINE | ANI Pharmaceuticals, Inc. | 3cf751f2-a0c9-45d7-8acb-2bc61db0e4ac | 2024-02-14 | Warnings, Adverse reactions | MESALAMINE |
| Mesalamine | MESALAMINE | Aurobindo Pharma Limited | d6c0fc76-644e-4301-9672-f432061e3d37 | 2024-01-20 | Warnings, Adverse reactions | MESALAMINE |
| MESALAMINE | MESALAMINE | Alembic Pharmaceuticals Inc. | 87d3d62d-2dc3-4e6f-be33-cabbca12e8f7 | 2024-01-09 | Warnings, Adverse reactions | MESALAMINE |
| mesalamine | MESALAMINE | Teva Pharmaceuticals USA, Inc. | 8d27a608-3ba1-4799-be38-c00fb08ce3ce | 2023-12-19 | Warnings, Adverse reactions | MESALAMINE |
| Mesalamine Rectal | MESALAMINE | Amring Pharmaceuticals Inc. | 87de237c-febb-42ca-b2a4-b444396f8640 | 2023-12-15 | Warnings, Adverse reactions | MESALAMINE |
| Mesalamine | MESALAMINE | Sun Pharmaceutical Industries, Inc. | fd8b02de-7dfa-444d-a1f8-1436b578e0cb | 2023-12-01 | Warnings, Adverse reactions | MESALAMINE |
| Mesalamine | MESALAMINE | Mylan Pharmaceuticals Inc. | c8b93ea3-0367-4605-b87f-06c3812ff3b7 | 2023-11-30 | Warnings, Adverse reactions | MESALAMINE |
| MESALAMINE | MESALAMINE | Alembic Pharmaceuticals Limited | 4ef59b85-e5a5-479f-a1fe-e1cee4d87670 | 2022-11-07 | Warnings, Adverse reactions | MESALAMINE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 54092-189 | Pentasa | mesalamine | Takeda Pharmaceuticals America, Inc. | NDA | Current |
| 54092-189 | Pentasa | mesalamine | Takeda Pharmaceuticals America, Inc. | NDA | Current |
| 54092-189 | Pentasa | mesalamine | Shire US Manufacturing Inc. | NDA | Current |
| 54092-189 | Pentasa | mesalamine | Shire US Manufacturing Inc. | NDA | Current |
| 54092-189 | Pentasa | mesalamine | Takeda Pharmaceuticals America, Inc. | NDA | Current |
| 54092-189 | Pentasa | mesalamine | Takeda Pharmaceuticals America, Inc. | NDA | Current |
| 54092-189 | Pentasa | mesalamine | Takeda Pharmaceuticals America, Inc. | NDA | Current |
| 54092-189 | Pentasa | mesalamine | Takeda Pharmaceuticals America, Inc. | NDA | Current |
| 54092-191 | Pentasa | mesalamine | Takeda Pharmaceuticals America, Inc. | NDA | Current |
| 54092-191 | Pentasa | mesalamine | Takeda Pharmaceuticals America, Inc. | NDA | Current |
| 54092-191 | Pentasa | mesalamine | Shire US Manufacturing Inc. | NDA | Current |
| 54092-191 | Pentasa | mesalamine | Shire US Manufacturing Inc. | NDA | Current |
| 54092-191 | Pentasa | mesalamine | Takeda Pharmaceuticals America, Inc. | NDA | Current |
| 54092-191 | Pentasa | mesalamine | Takeda Pharmaceuticals America, Inc. | NDA | Current |
| 54092-191 | Pentasa | mesalamine | Takeda Pharmaceuticals America, Inc. | NDA | Current |
| 54092-191 | Pentasa | mesalamine | Takeda Pharmaceuticals America, Inc. | NDA | Current |
| 68151-4769 | Pentasa | mesalamine | Carilion Materials Management | NDA | Current |
| 69189-0189 | Pentasa | mesalamine | Avera McKennan Hospital | NDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 79272 | SUPPL | 2024-08-02 |
| 79259 | SUPPL | 2024-07-31 |
| 75938 | SUPPL | 2023-10-25 |
| 75926 | SUPPL | 2023-10-25 |
| 72642 | SUPPL | 2022-11-17 |
| 72630 | SUPPL | 2022-11-17 |
| 69207 | SUPPL | 2021-11-02 |
| 69200 | SUPPL | 2021-11-02 |
| 67656 | SUPPL | 2021-06-02 |
| 67598 | SUPPL | 2021-05-26 |
| 65770 | SUPPL | 2020-12-28 |
| 65113 | SUPPL | 2020-11-02 |
| 64863 | SUPPL | 2020-10-07 |
| 64796 | SUPPL | 2020-10-02 |
| 59369 | SUPPL | 2019-07-18 |
| 59364 | SUPPL | 2019-07-17 |
| 54380 | SUPPL | 2018-05-31 |
| 54318 | SUPPL | 2018-05-24 |
| 49539 | SUPPL | 2017-08-25 |
| 49533 | SUPPL | 2017-08-24 |
| 49142 | SUPPL | 2017-07-31 |
| 49126 | SUPPL | 2017-07-28 |
| 41135 | SUPPL | 2015-11-18 |
| 21080 | SUPPL | 2015-08-10 |
| 34209 | SUPPL | 2015-08-07 |
| 21079 | SUPPL | 2013-12-17 |
| 12163 | SUPPL | 2013-12-17 |
| 34208 | SUPPL | 2013-07-30 |
| 21078 | SUPPL | 2013-07-26 |
| 41134 | SUPPL | 2007-11-19 |
| 21077 | SUPPL | 2007-07-05 |
| 1951 | SUPPL | 2006-07-03 |
| 1950 | SUPPL | 2004-07-14 |
| 41133 | SUPPL | 1999-09-10 |
| 21076 | SUPPL | 1999-09-10 |
| 12162 | SUPPL | 1999-09-10 |
| 41132 | ORIG | 1998-02-18 |